Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank93
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
116.36%
↑ 694% vs avg
Percentile
P93
Near historical high
Streak
1 yr
Consecutive growthAccelerating
Average
-19.59%
Historical baseline
PeriodValue
2025116.36%
2024-193.21%
2023-14.84%
2022-19.77%
2021-59.98%
2020-252.24%
2019209.39%
2018-51.20%
201754.74%
201614.83%